Summary of Key Points Core Viewpoint - Tianyi Medical's stock experienced a decline of 2.77% on August 28, with a trading volume of 66.35 million yuan, indicating potential market volatility and investor sentiment concerns [1]. Financing and Trading Data - On August 28, Tianyi Medical had a financing purchase amount of 10.72 million yuan and a net financing purchase of 5.96 million yuan, with a total financing and securities balance of 31.14 million yuan, accounting for 3.83% of its market capitalization [1]. - The financing balance is above the 80th percentile of the past year, indicating a high level of financing activity [1]. - There were no short sales or repayments on the same day, with the short selling balance also at zero, placing it in the 90th percentile of the past year [1]. Company Overview - Tianyi Medical, established on March 12, 1998, and listed on April 7, 2022, specializes in the research, production, and sales of medical devices, particularly in blood purification and ward care [1]. - The company's revenue composition includes 59.05% from blood purification, 34.08% from ward care, and 6.87% from other sources [1]. Financial Performance - For the first half of 2025, Tianyi Medical reported a revenue of 227 million yuan, reflecting a year-on-year growth of 11.50%, while the net profit attributable to shareholders decreased by 35.23% to 9.48 million yuan [2]. - The total number of shareholders as of June 30 was 4,196, a slight decrease of 0.31%, with an average of 4,372 circulating shares per person, which increased by 0.31% [2]. Dividend and Shareholder Information - Since its A-share listing, Tianyi Medical has distributed a total of 102 million yuan in dividends, with 87.50 million yuan distributed over the past three years [3]. - As of June 30, 2025, the top ten circulating shareholders included notable funds, with some holdings remaining stable while others saw slight reductions [3].
天益医疗8月28日获融资买入1071.93万元，融资余额3114.17万元